Literature DB >> 23493384

Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain.

Jennifer E Flythe1, Gary C Curhan, Steven M Brunelli.   

Abstract

BACKGROUND AND OBJECTIVES: Rapid ultrafiltration rate is associated with increased mortality among hemodialysis patients. Ultrafiltration rates are determined by interdialytic weight gain and session length. Although both interdialytic weight gain and session length have been linked to mortality, the relationship of each to mortality, independent of the other, is not adequately defined. This study was designed to evaluate whether shorter session length independent of weight gain and larger weight gain independent of session length are associated with increased mortality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Data were taken from a national cohort of 14,643 prevalent, thrice-weekly, in-center hemodialysis patients dialyzing from 2005 to 2009 (median survival time, 25 months) at a single dialysis organization. Patients with adequate urea clearance and delivered dialysis session ≥240 and <240 minutes were pair-matched on interdialytic weight gain (n=1794), and patients with weight gain ≤3 and >3 kg were pair-matched on session length (n=2114); mortality associations were estimated separately.
RESULTS: Compared with delivered session length ≥240, session length <240 minutes was associated with increased all-cause mortality (adjusted hazard ratio [95% confidence interval], 1.32 [1.03 to 1.69]). Compared with weight gain ≤3, weight gain >3 kg was associated with increased mortality (1.29 [1.01 to 1.65]). The associations were consistent across strata of age, sex, weight, and weight gain and session length. Secondary analyses demonstrated dose-response relationships between both and mortality.
CONCLUSIONS: Among patients with adequate urea clearance, shorter dialysis session length and greater interdialytic weight gain are associated with increased mortality; thus, both are viable targets for directed intervention.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23493384      PMCID: PMC3700694          DOI: 10.2215/CJN.09460912

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  31 in total

1.  Measurement of dialyzer clearance, dialysis time, and body size: death risk relationships among patients.

Authors:  Edmund G Lowrie; Zhensheng Li; Norma Ofsthun; J Michael Lazarus
Journal:  Kidney Int       Date:  2004-11       Impact factor: 10.612

2.  Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.

Authors:  Xiao-Ming Gao; Geoffrey Wong; Binghui Wang; Helen Kiriazis; Xiao-Lei Moore; Yi-Dan Su; Anthony Dart; Xiao-Jun Du
Journal:  J Hypertens       Date:  2006-08       Impact factor: 4.844

3.  Minimized weight gain between hemodialysis contributes to a reduced risk of death.

Authors:  B G Stegmayr; M Brannstrom; S Bucht; E Dimeny; A Ekspong; B Granroth; K C Grontoft; H Hadimeri; B Holmberg; B Ingman; B Isaksson; G Johansson; K Lindberger; L Lundberg; O Lundstrom; L Mikaelsson; M Mortzell; E Olausson; B Persson; L Svensson; A M Wikdahl
Journal:  Int J Artif Organs       Date:  2006-07       Impact factor: 1.595

Review 4.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

5.  Repeated stunning precedes myocardial hibernation in progressive multiple coronary artery obstruction.

Authors:  B Shivalkar; W Flameng; M Szilard; S Pislaru; M Borgers; J Vanhaecke
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

6.  Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS.

Authors:  R Saran; J L Bragg-Gresham; N W Levin; Z J Twardowski; V Wizemann; A Saito; N Kimata; B W Gillespie; C Combe; J Bommer; T Akiba; D L Mapes; E W Young; F K Port
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

7.  Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients.

Authors:  M R Marshall; B G Byrne; P G Kerr; S P McDonald
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

Review 8.  The mechanisms of atrial fibrillation.

Authors:  Peng-Sheng Chen; Chung-Chuan Chou; Alex Y Tan; Shengmei Zhou; Michael C Fishbein; Chun Hwang; Hrayr S Karagueuzian; Shien-Fong Lin
Journal:  J Cardiovasc Electrophysiol       Date:  2006-12

9.  Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study.

Authors:  Ezio Movilli; Paola Gaggia; Roberto Zubani; Corrado Camerini; Valerio Vizzardi; Giovanni Parrinello; Silvana Savoldi; Marie Stephanie Fischer; Francesco Londrino; Giovanni Cancarini
Journal:  Nephrol Dial Transplant       Date:  2007-09-21       Impact factor: 5.992

10.  Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine.

Authors:  J Törnig; K Amann; E Ritz; C Nichols; M Zeier; G Mall
Journal:  J Am Soc Nephrol       Date:  1996-05       Impact factor: 10.121

View more
  32 in total

1.  Posthemodialysis weights and mortality: another narrow range target?

Authors:  Kristen L Jablonski; Michel Chonchol
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-10       Impact factor: 8.237

Review 2.  The potential of electrocardiography for cardiac risk prediction in chronic and end-stage kidney disease.

Authors:  Sofia Skampardoni; Dimitrios Poulikakos; Marek Malik; Darren Green; Philip A Kalra
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

3.  Association of mortality risk with various definitions of intradialytic hypotension.

Authors:  Jennifer E Flythe; Hui Xue; Katherine E Lynch; Gary C Curhan; Steven M Brunelli
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

Review 4.  The relationship of volume overload and its control to hypertension in hemodialysis patients.

Authors:  Jennifer E Flythe; Nisha Bansal
Journal:  Semin Dial       Date:  2019-09-29       Impact factor: 3.455

5.  Fluid First or Not So Fast: Ultrafiltration Rate and the ESRD Quality Incentive Program.

Authors:  Daniel E Weiner; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-22       Impact factor: 8.237

6.  Diagnosis and Treatment of Intradialytic Hypotension in Maintenance Hemodialysis Patients.

Authors:  Christopher W McIntyre; Fabio R Salerno
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-02       Impact factor: 8.237

7.  No Survival Benefit in Octogenarians and Nonagenarians with Extended Hemodialysis Treatment Time.

Authors:  Gang Jee Ko; Yoshitsugu Obi; Melissa Soohoo; Tae Ik Chang; Soo Jeong Choi; Csaba P Kovesdy; Elani Streja; Connie M Rhee; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2018-11-13       Impact factor: 3.754

Review 8.  Single needle hemodialysis: is the past the future?

Authors:  Raymond Vanholder
Journal:  J Nephrol       Date:  2019-09-19       Impact factor: 3.902

Review 9.  Rapid ultrafiltration rates and outcomes among hemodialysis patients: re-examining the evidence base.

Authors:  Magdalene M Assimon; Jennifer E Flythe
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-11       Impact factor: 2.894

10.  Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.

Authors:  Yoshitsugu Obi; Elani Streja; Connie M Rhee; Vanessa Ravel; Alpesh N Amin; Adamasco Cupisti; Jing Chen; Anna T Mathew; Csaba P Kovesdy; Rajnish Mehrotra; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2016-02-09       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.